Efficacy and Safety of ABP-450 (PrabotulinumtoxinA) in Adults With Cervical Dystonia: Results From the Open-label Extension of a Phase 2 Trial

被引：0

作者：

Jankovic, Joseph ^{[1
]}

Oh, Chad ^{[2
]}

Liu, Yan ^{[2
]}

Abdul-Musawir, Najeebah ^{[2
]}

Comella, Cynthia ^{[3
]}

机构：

[1] Baylor Coll Med, St Lukes Med Ctr, Dept Neurol, Parkinsons Dis Ctr & Movement Disorders Clin, McNair Campus,7200 Cambridge St,Suite 9A, Houston, TX USA

[2] AEON Biopharma Inc, Irvine, CA USA

[3] Rush Univ, Med Ctr, Chicago, IL USA

来源：

TOXICON | 2024年 / 237卷

关键词：

Cervical dystonia; Type A botulinum toxins; PrabotulinumtoxinA; Torticollis; Dyskinesias; Neurologic manifestations;

D O I：

10.1016/j.toxicon.2024.107415

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：36 / 37

页数：3

共 50 条

[31] EFFICACY AND SAFETY OF 108 WEEKS' BIMEKIZUMAB TREATMENT IN PATIENTS WITH PSORIATIC ARTHRITIS: INTERIM RESULTS FROM A PHASE 2 OPEN-LABEL EXTENSION STUDY
Mcinnes, I.
Merola, J. F.
Mease, P. J.
Coates, L. C.
Joshi, P.
Coarse, J.
Ink, B.
Ritchlin, C. T.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1149 - 1150
[32] Efficacy and Safety of 108 Weeks of Bimekizumab Treatment in Patients with Psoriatic Arthritis: Interim Results from a Phase 2 Open-Label Extension Study
McInnes, I. B.
Merola, J. F.
Mease, P. J.
Coates, L. C.
Schmitz, N.
Joshi, P.
Coarse, J.
Ink, B.
Ritchlin, C. T.
SWISS MEDICAL WEEKLY, 2020, : 7S - 8S
[33] Safety and Efficacy of Subcutaneous Tocilizumab in Early Systemic Sclerosis: Results from the Open-Label Period of a Phase 2 Randomized, Controlled Trial
Khanna, Dinesh
Denton, Christopher
Spotswood, Helen
Jahreis, Angelika
van Laar, Jacob M.
Burke, Laura
Lin, Celia J. F.
Pope, Janet E.
Allanore, Yannick
Mueller-Ladner, Ulf
Siegel, Jeffrey
Furst, Daniel E.
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[34] Commentary on "Efficacy and Safety of PrabotulinumtoxinA in Subjects With Benign Masseteric Hypertrophy: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase 3 Trial and Open-Label Extension Study"
Hausauer, Amelia K.
DERMATOLOGIC SURGERY, 2024, 50 (06) : 534 - 534
[35] Efficacy and Safety of Viltolarsen in Boys With Duchenne Muscular Dystrophy: Results From the Phase 2, Open-Label, 4-Year Extension Study
Clemens, Paula R.
Rao, Vamshi K.
Connolly, Anne M.
Harper, Amy D.
Mah, Jean K.
McDonald, Craig M.
Smith, Edward C.
Zaidman, Craig M.
Nakagawa, Tomoyuki
Hoffman, Eric P.
JOURNAL OF NEUROMUSCULAR DISEASES, 2023, 10 (03) : 439 - 447
[36] TOFERSEN IN ADULTS WITH SOD1-ALS: PHASE 3 VALOR TRIAL AND OPEN-LABEL EXTENSION RESULTS
Shaw, Pamela
Miller, Timothy
Cudkowicz, Merit
Genge, Angela
Sobue, Gen
Nestorov, Ivan
Graham, Danielle
Fanning, Laura
Fradette, Stephanie
McNeill, Manjit
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (09):
[37] An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis
Cohen, Stanley
Pablos, Jose L.
Pavelka, Karel
Mueller, Gerard Anton
Matsumoto, Alan
Kivitz, Alan
Wang, Hui
Krishnan, Eswar
ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
[38] An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis
Stanley Cohen
Jose L. Pablos
Karel Pavelka
Gerard Anton Müller
Alan Matsumoto
Alan Kivitz
Hui Wang
Eswar Krishnan
Arthritis Research & Therapy, 21
[39] Safety and efficacy of retreatment with a bioengineered hyaluronate for painful osteoarthritis of the knee: results of the open-label Extension Study of the FLEXX Trial
Altman, R. D.
Rosen, J. E.
Bloch, D. A.
Hatoum, H. T.
OSTEOARTHRITIS AND CARTILAGE, 2011, 19 (10) : 1169 - 1175
[40] SAFETY AND EFFICACY OF RETREATMENT WITH A BIOENGINEERED HYALURONATE FOR PAINFUL OSTEOARTHRITIS OF THE KNEE: RESULTS OF THE OPEN-LABEL EXTENSION STUDY OF THE FLEXX TRIAL
Altman, R. D.
Rosen, J. E.
Bloch, D. A.
Hatoum, H. T.
OSTEOARTHRITIS AND CARTILAGE, 2011, 19 : S144 - S144

← 1 2 3 4 5 →